Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cistus incanus is a **botanical herbal extract** derived from the Mediterranean shrub *Cistus incanus* and enriched in polyphenolic constituents including flavonoids, phenolic acids, and myricitrin. It is not an approved pharmaceutical active ingredient but has been investigated as a **dietary supplement and botanical antiviral product**, including the branded extract CYSTUS052 for upper respiratory tract infections and viral inhibition studies, and as a topical cosmetic ingredient in IBR-Chill for stress-related skin inflammation. Its proposed mechanism is predominantly **direct interaction with pathogen surface and envelope proteins**, which can reduce viral attachment and entry into host cells rather than acting through a single well-defined human molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cistus incanus.